Blood Pressure Control Pharmacotherapy

advertisement

Blood Pressure Control – Pharmacotherapy

Source DiGP/HSE/UCC Diabetes in Primary Care Conference 26

th

Sept 2012

Pharmacotherapy

Medication type/classifications Advantages of this medication

First line therapy -

ACE Inhibitors (ACEI)

Vasodilators

Effective blood pressure lowering agents

Reno-protective effect

Reduce cardiovascular morbidity and mortality

Long term data available for its efficacy

Potential side effects and/or notes of caution when choosing this medication

Cough (switch to ARB)

Angioedema

Hyperkalaemia

If prescribing in patients with renal failure – check U&E 2 weeks after starting

Caution in patients with renal artery stenosis

Teratogenic – do not use in patients planning pregnancy

Hyperkalaemia

If prescribing in patients with renal failure – check U&E 2 weeks after starting

Caution in patients with renal artery stenosis

First line therapy - Angiotensin

Receptor Blockers (ARB)

Effective blood pressure lowering agents

Vasodilators Reno-protective effect

Reduce cardiovascular morbidity and mortality

Long term data available for its efficacy

Second line therapy – Calcium

Channel Blocker

Vasodilators

Second line therapy –

Diuretic therapy (thiazide diuretic)

Diuretic

Natriuresis

Effective blood pressure lowering agents

Reduce cardiovascular morbidity and mortality

Long term data available for its efficacy

Effective blood pressure lowering agents

Reduce cardiovascular morbidity and mortality

Long term data available for its efficacy

Leg oedema

Constipation

Hyponatraemia

Dehydration

Gout

Hyperkalaemia

Avoid high dose thiazide diuretics such as bendrofluazide 5mg as this dose is associated with hyperglycaemia

Caution in elderly patients with low BMI

– increased risk of hyponatraemia

Medication type/classifications Advantages of this medication

Third Line Therapy* Effective blood pressure lowering agents

Beta- Blockers

Reduce heart rate

Reduce cardiovascular morbidity and mortality

Reduce myocardial contractility

Long term data available for its efficacy

*Cardio-selective beta blockers should be used

*Beta-blockers should be used as first line BP agents in patients with

co-existing angina

Lowers blood pressure Fourth Line Therapy

Aldosterone antagonist e.g. eplerenone or spironolactone

Diuretic

Block the action of aldosterone

Fourth Line Therapy – Alpha

Blocker e,g, doxazosin XL

Vasodilator

Lower Blood Pressure

Safe to prescribe in renal failure

Potential side effects and/or notes of caution when choosing this medication

Bradycardia

Fatigue

Cold peripheries

Dizziness

Hyperkalaemia

Dehydration

Hyponatraemia

Gynaecomastia with spironolactone only

Caution: high risk of hyperkalaemia if used in combination with ACEI or ARB

Dizziness

Postural hypotension

Increased urinary frequency

Source: National Diabetes Working Group

Notes re Treatment of Hypertension:

The renin antagonist (alsikerin) has recently been associated with a high risk of hyperkalaemia and increased risk of non-fatal stroke in patients with diabetes and so is currently not recommended as a routine blood pressure treatment for patients with type 2 diabetes.

Combination treatment of an ACEI and ARB is associated with a high risk of hyperkalaemia and increased risk of renal dysfunction and therefore combination therapy of an ACEI or ARB should be used with caution and under the supervision of a specialist.

In patients of Afro-Caribbean descent first line treatment for Blood Pressure is an ACEI in combination with a

Calcium Channel Blocker or a thiazide diuretic (do not use an ACEI on its own)

Patients with type 2 diabetes frequently have refractory or resistant hypertension despite the use of 3 or 4 blood pressure agents. If this is the case with a patient then seek expert advice from a consultant endocrinologist as per national model of care.

The following are treatment algorithms to help guide you in the medication management of Blood Pressure in Type 2 diabetes. All treatment should again be given in conjunction with advice on diet, reduced alcohol intake, exercise and weight loss where appropriate.

Treatment of Patients with High Blood Pressure and Type 2 Diabetes

See Options 1, 2 & 3. Choose Option 3 in patients with angina or following MI

Option 1

Add Calcium Channel Blocker

Add Thiazide Diuretic

(combination tablets with

ACEI & ARB available)

Add Beta Blocker

Start ACE Inhibitor

( If cough or other side effects on ACEI switch to Angiotensin

Receptor Blocker)

Blood Pressure remains above target then introduce extra BP lowering medications in a step-wise fashion.

Option 2

Add thiazide diuretic

(combination tablets with

ACEI & ARB available)

Add Calcium Channel Blocker

Add Beta Blocker

Option 3

Patients with angina or post-MI

Add beta blocker

Add Calcium Channel Blocker

Add thiazide diuretic

(combination tablets with

ACEI & ARB available)

Source: National Diabetes

Working Group

Ask for expert opinion

Consider addition of

1. Alpha-Blocker or

2. Aldosterone Anatagonist or

3. Use of combination ACEI or ARB

Download